I believe the big question for the future is, if we partner with a big Pharma with worldwide rights, does that company treat our products as a drug, which could mean several years of trials before approvals and sales, or will they treat it as a nutraceutical/cosmetic, which could almost immediately go on the market.

I think our price would reach new highs either way, but I really don't know which direction achieves the greatest value for the company.

Drug companies like marketing drugs, so I'm inclined to think a big Pharma that partnered our psoriasis cream would move it into Phase 2, or possibly Phase 3 Trials, depending on the efficacy shown in the trial which will eventually be reported. If they could do Phase 3 Trials, I would suspect the size and duration of the trial demanded by the FDA would take at least a couple years to approval, perhaps substantially longer if a Phase 2 must be done before a Phase 3.

Gary